InvestorsHub Logo
Followers 67
Posts 16221
Boards Moderated 2
Alias Born 02/14/2011

Re: None

Tuesday, 10/09/2012 10:39:01 AM

Tuesday, October 09, 2012 10:39:01 AM

Post# of 152
7:41 AM On the back of positive results for its Alzheimer's treatment, Eli Lilly (LLY) is upgraded to Neutral with $54 price target from Sell and $42 at Goldman. "Our skepticism was proven wrong." Shares +1% premarket.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LLY News